05.08.2011 • NewsHuntsmanQ2 2011sales and profits

Huntsman Q2 Adjusted Profit Up

Huntsman posted second-quarter net income attributable to the company of $114 million or $0.47 per share, flat with last year. Adjusted net income for the second quarter rose to $117 million or $0.48 per share from $75 million or $0.31 per share in the year-ago quarter.

Analysts polled by Thomson Reuters expected the company to earn $0.49 per share in the quarter. Analysts' estimates typically exclude special items.

Revenues were $2.93 billion versus $2.34 billion last year. The Street estimated revenues of $2.77 billion for the quarter.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.